@prefix this: . @prefix sub: . @prefix schema: . @prefix np: . @prefix dct: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix bl: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { bl:category bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "benzphetamine hydrochloride tablets are indicated in the management of exogenous obesity as a short term a few weeks adjunct in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index bmi of 3 kg m2 or higher who have not responded to appropriate weight reducing regimen diet and or exercise alone below is a chart of body mass index bmi based on various heights and weights bmi is calculated by taking the patient s weight in kilograms kg divided by the patient s height in meters m squared metric conversions are as follows pounds 2 2 kg inches x 254 meters the limited usefulness of agents of this class see clinical pharmacology body mass index bmi kg m 2 weight pounds height feet inches 5 5 3 5 6 5 9 6 6 3 14 27 25 23 21 19 18 15 29 27 24 22 2 19 16 31 28 26 24 22 2 17 33 3 28 25 23 21 18 35 32 29 27 25 23 19 37 34 31 28 26 24 2 39 36 32 3 27 25 21 41 37 34 31 29 26 22 43 39 36 33 3 28 23 45 41 37 34 31 29 24 47 43 39 36 33 3 25 49 44 4 37 34 31 benzphetamine hydrochloride tablets are indicated for use as monotherapy only"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by ; bl:relation schema:TreatmentIndication . bl:category bl:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "Vc/oSGieO7kXVoXEFofWWyFyjgbdkfY8dAbkRTV1YWpYs4lsDtLzyvdbaQZh61qvXF2YFZf2ZJRzUaFi5e8ZeP+Ld7v2VqnC4HmFc6zfWAsxGJ9rTT3dfmvC5thd6Rz3/oWU6euVdLl6KIX7F4BKjshdBFJIv/02c60f5kj76cA="; npx:hasSignatureTarget this: . this: dct:created "2021-06-21T10:06:06.497+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }